BELLICUM PHARMACEUTICALS INC's ticker is BLCM and the CUSIP is 079481107. A total of 78 filers reported holding BELLICUM PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is 3.64 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $516,000 | -34.5% | 400,000 | -46.7% | 0.04% | -64.8% |
| Q3 2019 | $788,000 | -73.0% | 750,000 | +200.0% | 0.12% | -75.4% |
| Q2 2017 | $2,920,000 | +18.3% | 250,000 | +25.0% | 0.50% | +2.9% |
| Q1 2017 | $2,468,000 | -47.4% | 200,000 | -13.6% | 0.48% | -29.8% |
| Q4 2015 | $4,693,000 | +39.5% | 231,515 | +0.0% | 0.69% | +60.1% |
| Q3 2015 | $3,364,000 | -31.7% | 231,514 | 0.0% | 0.43% | -11.0% |
| Q2 2015 | $4,924,000 | -13.5% | 231,514 | -7.2% | 0.48% | -18.7% |
| Q1 2015 | $5,693,000 | – | 249,567 | – | 0.59% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Virtus ETF Advisers LLC | 15,086 | $306,000 | 0.84% |
| Baker Brothers Advisors | 4,865,647 | $98,627,000 | 0.82% |
| Cormorant Asset Management, LP | 300,000 | $6,081,000 | 0.73% |
| SPHERA FUNDS MANAGEMENT LTD. | 231,515 | $4,693,000 | 0.69% |
| QVT Financial LP | 340,986 | $6,912,000 | 0.39% |
| Graticule Asia Macro Advisors LLC | 87,000 | $1,763,000 | 0.29% |
| Hatteras Investment Partners, LP | 10,410 | $211,000 | 0.28% |
| MCDANIEL TERRY & CO | 33,836 | $686,000 | 0.18% |
| Highlander Capital Management, LLC | 6,500 | $132,000 | 0.12% |
| EverPoint Asset Management, LLC | 265,000 | $5,372,000 | 0.11% |